Ovarian hormones are considered to be capable of regulating expression of β β β β-catenins. A possible role of β β β β-catenin in alteration of cell morphology has been proposed, but little is known about β β β β-catenin expression during changes in the tumor morphology of endometrial carcinomas induced by progesterone therapy. To clarify changes in expression of β β β β-catenin and their relation to morphological alteration, expression of hormone receptors and several cell kinetic markers, sequential biopsy and hysterectomy specimens of 23 endometrial carcinoma and 6 complex hyperplasia with atypia (atypical hyperplasia) cases receiving progesterone therapy were investigated. In vitro assay was also conducted using two endometrial carcinoma cell lines (HEC265 and Ishikawa) expressing progesterone receptors (PRs). An increase of nuclear β β β β-catenin accumulation was evident during progesterone therapy in endometrial carcinomas and atypical hyperplasias. he most successful approach to the treatment of endometrial carcinoma is hysterectomy with bilateral salpingooophorectomy, combined with cytotoxic chemotherapy and radiation therapy employed for advanced or recurrent tumors. Hormone therapy on the basis of the profound maturation-stimulating effects of progesterone is also applied for tumors in young patients to avoid the necessity of hysterectomy. 1) Such therapy alone, however, is not considered to be sufficient to eradicate carcinomas from the endometrium, since alterations in tumor morphology through cell maturation or differentiation are induced, but not cell death.
2, 3)β-Catenin was originally identified as a major component of the cadherin adhesion system, binding to both E-cadherin cytoplasmic and α-catenin amino-terminal domains.4) The cytoplasmic level of β-catenin is tightly regulated through degradation via the ubiquitin-proteasome pathway, whereby serine and threonine residues in exon 3 are phosphorylated by glycogen synthetase kinase (GSK)-3β and ubiquitinylated by binding to proteins such as adenomatous polyposis coli (APC), and axin.
5)Stabilization of cytoplasmic β-catenin due to up-regulation of wingless/wnt signalling or abnormalities of either APC or β-catenin proteins can lead to its interaction with nuclear transcription factors of the T cell factor-lymphoid enhancer factor (TCF/LEF) family, resulting in activation of target genes. [6][7][8] Recently, ovarian hormones have been reported to be capable of regulating several cell adhesion-related molecules, including E-cadherin, α-and β-catenins and cad-11.9-11) Moreover, changes in expression level and subcellular distribution of the β-catenin occur during morphological alterations through cell differentiation in several colorectal carcinoma cell lines. 12,13) Our previous findings indicated that β-catenin abnormalities may play an important role in relatively early events during the endometrial hyperplasia-carcinoma sequence.14) In the present study, to clarify possible associations between β-catenin and alteration of morphology in respon...